Studies related to Quality of Life and Oxiracetam

Oxiracetam In Dementia: A Double-blind, Placebo-controlled Study

Effect Increase
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 58
Sex Both Genders
Age Range 65+
Notes for this study:
1,600mg of oxiracetam given twice daily to persons with dementia was able to reduce symptoms of cognitive decline over 12 weeks and improve verbal learning (short story test) and quality of life.